Compounding Pharmacy Insurance Billing for GLP-1

By Insurance Review Editorial ·

Compounding Pharmacy Insurance Billing for GLP-1

The landscape around compounding pharmacy insurance billing for glp 1 continues to evolve as new studies emerge and treatment protocols improve. This article captures the most up-to-date thinking on the subject.


Plan Details

Our analysis of this plan reveals important factors for patients seeking Ozempic or Wegovy:


Your Out-of-Pocket

Estimating your out-of-pocket expense means considering multiple factors:

| Element | Estimate | |---|---| | Monthly copay | $25-150 | | Deductible applies | Often yes | | Annual max OOP | plan-specific | | Copay assistance | Usually yes |

After meeting your deductible, most policies shift to cost-sharing ranging from 20-50% before you meet your annual OOP max.


Steps to Approval

  1. Review plan documents — Find the drug list online or call member services
  2. Build your case — Your prescriber should submit medical necessity with BMI, comorbidities and failed prior treatments
  3. File the PA — The prescriber sends the PA request to the PBM
  4. Challenge denials — When rejected, there is a legal right to appeal the refusal — approval on appeal are surprisingly high

Rating

Considering all factors, approval difficulty, and patient cost, we score this option for Ozempic and Wegovy users:


Frequently Asked Questions

Does this plan cover Ozempic?

The answer is contingent upon which plan tier and the medical indication. Diabetes diagnoses have higher approval rates to be covered compared to obesity uses.

What if my prior authorization is denied?

Appeal the decision right away. Attach supporting medical records from your doctor. Many denials are reversed when challenged with thorough documentation.